Healthcare provider profile · identity verified

Stephanie A. Mccardle, MD

Family Practice · BROWNSBURG, IN · NPI 1053342543

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	481	161
Amlodipine Besylate	Amlodipine Besylate	276	110
Gabapentin	Gabapentin	226	81
Furosemide	Furosemide	191	55
Albuterol Sulfate Hfa	Albuterol Sulfate	179	83
Levothyroxine Sodium	Levothyroxine Sodium	179	45
Lisinopril	Lisinopril	179	63
Trazodone Hcl	Trazodone Hcl	147	51
Sertraline Hcl	Sertraline Hcl	137	43
Losartan Potassium	Losartan Potassium	136	50
Pantoprazole Sodium	Pantoprazole Sodium	127	45
Potassium Chloride	Potassium Chloride	126	34
Duloxetine Hcl	Duloxetine Hcl	118	28
Omeprazole	Omeprazole	114	40
Carvedilol	Carvedilol	111	27
Metformin Hcl	Metformin Hcl	108	41
Metoprolol Succinate	Metoprolol Succinate	107	47
Prednisone	Prednisone	90	59
Tamsulosin Hcl	Tamsulosin Hcl	89	38
Ozempic	Semaglutide	88	26
Jardiance	Empagliflozin	86	23
Eliquis	Apixaban	83	25
Fluticasone Propionate	Fluticasone Propionate	76	31
Hydrochlorothiazide	Hydrochlorothiazide	74	30
Myrbetriq	Mirabegron	68	18
Buspirone Hcl	Buspirone Hcl	66	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	19
Escitalopram Oxalate	Escitalopram Oxalate	63	16
Famotidine	Famotidine	63	19
Donepezil Hcl	Donepezil Hcl	58	12
Clopidogrel	Clopidogrel Bisulfate	57	23
Tramadol Hcl	Tramadol Hcl	57	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	21
Cephalexin	Cephalexin	53	45
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	28
Levetiracetam	Levetiracetam	52	suppressed
Torsemide	Torsemide	52	14
Allopurinol	Allopurinol	50	21
Metoprolol Tartrate	Metoprolol Tartrate	49	19
Metformin Hcl Er	Metformin Hcl	47	18
Hydralazine Hcl	Hydralazine Hcl	45	11
Mirtazapine	Mirtazapine	45	20
Spironolactone	Spironolactone	45	13
Rosuvastatin Calcium	Rosuvastatin Calcium	44	23
Topiramate	Topiramate	44	16
Diclofenac Sodium	Diclofenac Sodium	43	22
Meloxicam	Meloxicam	41	17
Tizanidine Hcl	Tizanidine Hcl	41	14
Bupropion Xl	Bupropion Hcl	40	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	29
Ondansetron Odt	Ondansetron	39	20
Baclofen	Baclofen	37	suppressed
Entresto	Sacubitril/Valsartan	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	13
Pregabalin	Pregabalin	37	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	13
Hydroxyzine Hcl	Hydroxyzine Hcl	35	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Methylprednisolone	Methylprednisolone	32	31
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Valsartan	Valsartan	32	12
Mounjaro	Tirzepatide	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Galantamine Hbr	Galantamine Hbr	29	suppressed
Glimepiride	Glimepiride	27	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Finasteride	Finasteride	25	suppressed
Nystatin	Nystatin	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	11
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Nitroglycerin	Nitroglycerin	22	13
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Azithromycin	Azithromycin	21	21
Digoxin	Digoxin	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Glipizide	Glipizide	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Naproxen	Naproxen	20	12
Trulicity	Dulaglutide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Atenolol	Atenolol	18	suppressed
Fluconazole	Fluconazole	18	12
Alendronate Sodium	Alendronate Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Amoxicillin	Amoxicillin	17	17
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	11
Verapamil Sr	Verapamil Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Gemtesa	Vibegron	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Celecoxib	Celecoxib	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Klayesta	Nystatin	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error